These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 1730782

  • 1. Quantitative dissociation between EGF effects on c-myc and c-fos gene expression, DNA synthesis, and epidermal growth factor receptor tyrosine kinase activity.
    Hauguel-DeMouzon S, Csermely P, Zoppini G, Kahn CR.
    J Cell Physiol; 1992 Jan; 150(1):180-7. PubMed ID: 1730782
    [Abstract] [Full Text] [Related]

  • 2. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ, Ince C, Rosenblum MG, Gallick GE.
    J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
    [Abstract] [Full Text] [Related]

  • 3. 2-Aminopurine abolishes EGF- and TPA-stimulated pp33 phosphorylation and c-fos induction without affecting the activation of protein kinase C.
    Mahadevan LC, Wills AJ, Hirst EA, Rathjen PD, Heath JK.
    Oncogene; 1990 Mar; 5(3):327-35. PubMed ID: 2107492
    [Abstract] [Full Text] [Related]

  • 4. Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response.
    Rozengurt E, Sinnett-Smith JW.
    J Cell Physiol; 1987 May; 131(2):218-25. PubMed ID: 3108267
    [Abstract] [Full Text] [Related]

  • 5. Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells.
    Izumi H, Ono M, Ushiro S, Kohno K, Kung HF, Kuwano M.
    Exp Cell Res; 1994 Oct; 214(2):654-62. PubMed ID: 7523156
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone attenuation of epidermal growth factor-induced mitogenesis.
    Wiepz GJ, Houtman JC, Cha D, Bertics PJ.
    J Cell Physiol; 1997 Oct; 173(1):44-53. PubMed ID: 9326448
    [Abstract] [Full Text] [Related]

  • 7. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J, Spence MJ, Wallace PM, Forcier K, Hellström I, Vestal RE.
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [Abstract] [Full Text] [Related]

  • 8. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
    Deleu S, Pirson I, Clermont F, Nakamura T, Dumont JE, Maenhaut C.
    J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC, Keiser JA.
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation.
    Curran T, Bravo R, Müller R.
    Cancer Surv; 1985 Oct; 4(4):655-81. PubMed ID: 3939686
    [Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity.
    Gulli LF, Palmer KC, Chen YQ, Reddy KB.
    Cell Growth Differ; 1996 Feb; 7(2):173-8. PubMed ID: 8822200
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
    Nass SJ, Dickson RB.
    Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860
    [Abstract] [Full Text] [Related]

  • 16. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T, Kohno K, Kuwano M, Gopas J, Kung HF, Ono M.
    Oncogene; 1996 Apr 18; 12(8):1625-33. PubMed ID: 8622882
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory action of epiderstatin on EGF-stimulated growth of mouse epidermal. BALB/MK cells without direct effect on protein kinase activities.
    Osada H, Kikuchi K, Makishima F, Isono K.
    Oncol Res; 1994 Apr 18; 6(1):11-7. PubMed ID: 7919547
    [Abstract] [Full Text] [Related]

  • 18. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
    Brunton VG, Carlin S, Workman P.
    Anticancer Drug Des; 1994 Aug 18; 9(4):311-29. PubMed ID: 7916899
    [Abstract] [Full Text] [Related]

  • 19. Modulation of epidermal growth factor receptor activity and related responses by the 7-deazaguanine derivative, queuine.
    Langgut W, Reisser T, Kersten H, Nishimura S.
    Oncogene; 1993 Nov 18; 8(11):3141-7. PubMed ID: 8414516
    [Abstract] [Full Text] [Related]

  • 20. Cell cycle progression proteins (cyclins), oncogene expression, and signal transduction during the proliferative response of human hepatocytes to hepatocyte growth factor.
    Gómez-Lechón MJ, Guillén I, Ponsoda X, Fabra R, Trullenque R, Nakamura T, Castell JV.
    Hepatology; 1996 May 18; 23(5):1012-9. PubMed ID: 8621126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.